The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.
SMARCA4 alteration class and allelic status define biologically and clinically distinct subsets of tumors and support incorporating allelic status and functional mutation class into patient selection strategies for emerging BRM-targeted therapies.